Cargando…

Non-invasive biomarkers for identification of vanishing bile duct syndrome among children with acute cholestatic hepatitis

BACKGROUND: The identification of vanishing bile duct syndrome (VBDS) is still challenging before liver biopsy. This study tried to explore non-invasive biomarkers for identification of VBDS among children with acute cholestatic hepatitis. METHODS: Between January 2017 and December 2021, 192 childre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Neng-Li, Chen, Lian, Lin, Jing, Lu, Yi, Fang, Wei-Yuan, Xie, Xin-Bao, Wang, Jian-She
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644022/ https://www.ncbi.nlm.nih.gov/pubmed/37969129 http://dx.doi.org/10.21037/tp-23-305

Ejemplares similares

Infliximab-Induced Vanishing Bile Duct Syndrome
por: Eiswerth, Michael J, et al.
Publicado: (2022)

Vanishing Bile Duct Syndrome Associated With Estrogen
por: Benfield, John, et al.
Publicado: (2022)

FRI088 Vanishing Bile Duct Syndrome?
por: Malvar, Cyerwin Monique T, et al.
Publicado: (2023)

Vanishing Bile Duct Syndrome in the Presence of Hodgkin Lymphoma
por: Gaudel, Pramod, et al.
Publicado: (2022)

Anaplastic Large Cell Lymphoma and Vanishing Bile Duct Syndrome
por: Sreepati, Gouri, et al.
Publicado: (2016)

Vanishing Bile Duct Syndrome Preceding the Diagnosis of Hodgkin Lymphoma
por: Anugwom, Chimaobi, et al.
Publicado: (2020)

Shenqi Fuzheng Injection impairs bile duct ligation-induced cholestatic liver injury in vivo
por: Cao, Fei, et al.
Publicado: (2019)

Vanishing Bile Duct Syndrome Associated With Non-Hodgkin’s Lymphoma and Hepatitis E Virus Infection
por: Zafar, Mansoor, et al.
Publicado: (2022)

Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct–Ligated Mouse
por: Cai, Shi-Ying, et al.
Publicado: (2019)

Meropenem-induced vanishing bile duct syndrome: A case report
por: Zubarev, Alexandr, et al.
Publicado: (2020)

Vanishing Bile Duct Syndrome in a Patient With Recurrent Hodgkin Lymphoma
por: Nano, Olger, et al.
Publicado: (2023)

Fatal vanishing bile duct syndrome in Iranian patient with Hodgkin's lymphoma
por: Shokri, Fazlollah, et al.
Publicado: (2023)

Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice
por: Abshagen, Kerstin, et al.
Publicado: (2015)

Vanishing Bile Duct Syndrome in an Adult Patient: Case Report and Review of the Literature
por: Izzo, Paolo, et al.
Publicado: (2022)

A Disquiet Find: Anabolic-androgenic steroids and Vanishing Bile Duct Syndrome
por: Kalal, Chetan, et al.
Publicado: (2020)

Vanishing bile duct syndrome-related jaundice as the first presentation of Hodgkin lymphoma
por: Mellat-Ardakani, Milad, et al.
Publicado: (2023)

Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report
por: Xie, Wen, et al.
Publicado: (2018)

Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: A case report
por: Zhao, Zonghao, et al.
Publicado: (2017)

The protective effect of allopurinol on cholestatic liver injury induced by bile duct ligation.
por: Mun, K. C., et al.
Publicado: (1996)

Cholestatic Hepatitis with Small Duct Injury Associated with Celecoxib
por: Nayudu, Suresh Kumar, et al.
Publicado: (2013)

Ibuprofen Associated Acute Vanishing Bile Duct Syndrome and Toxic Epidermal Necrolysis in an Infant
por: Kim, Hye-young, et al.
Publicado: (2014)

Vanishing bile duct syndrome in Hodgkin’s lymphoma: A case report and literature review
por: Bakhit, Mena, et al.
Publicado: (2017)

Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic Sclerosis
por: Sedhom, Daniel, et al.
Publicado: (2018)

A rare presentation of vanishing bile duct syndrome in Hodgkin lymphoma: Case report
por: Patodiya, Bharat, et al.
Publicado: (2023)

Histopathological Features Predicting Long-term Clinical Outcomes in Patients with Vanishing Bile Duct Syndrome
por: Lv, Tingting, et al.
Publicado: (2023)

18β-Glycyrrhetinic Acid Protects against Cholestatic Liver Injury in Bile Duct-Ligated Rats
por: Pan, Pin-Ho, et al.
Publicado: (2022)

The Role of Gut Microbiota in Mice With Bile Duct Ligation-Evoked Cholestatic Liver Disease-Related Cognitive Dysfunction
por: Yang, Bowen, et al.
Publicado: (2022)

Urosodeoxycholic Acid Therapy in a Child with Trimethoprim-Sulfamethoxazole-induced Vanishing Bile Duct Syndrome
por: Cho, Hyun Jeong, et al.
Publicado: (2013)

A novel murine model of reversible bile duct obstruction demonstrates rapid improvement of cholestatic liver injury
por: Taylor, Sarah A., et al.
Publicado: (2020)

Vanishing Bile Duct Syndrome in a Hodgkin's Lymphoma Patient with Fatal Outcome Despite Lymphoma Remission
por: Aleem, Aamer, et al.
Publicado: (2013)

A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel
por: Piawah, Sorbarikor, et al.
Publicado: (2019)

A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen
por: Bak, Haein, et al.
Publicado: (2020)

Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis
por: Lin, Wan-Chen, et al.
Publicado: (2022)

L-carbocisteine can cause cholestasis with vanishing bile duct syndrome in children: A case report
por: Takaki, Yugo, et al.
Publicado: (2022)

Hodgkin lymphoma associated vanishing bile duct syndrome treated successfully with a brentuximab based regimen
por: Morgan, Judah D, et al.
Publicado: (2023)

Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats
por: Tian, Bin, et al.
Publicado: (2016)

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(−/−) mice by modulating composition, signalling and excretion of faecal bile acids
por: Fuchs, Claudia Daniela, et al.
Publicado: (2018)

A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma
por: Gourari, Karim, et al.
Publicado: (2022)

Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Wei, Shizhang, et al.
Publicado: (2020)

Now You See It, Now You Do Not: A Case of Infliximab-Induced Vanishing Bile Duct Syndrome
por: Shah, Parth, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_egp64fvo9h1g8bprn4udthvo9c